RNA–RNA interactome approaches provide in vivo evidence for a critical role of the Hfq rim face in sRNA–mRNA pairing
Nucleic Acids Research · 26.11.2025 · 53 (22)
DOI: 10.1093/nar/gkaf1313 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 12.12.2025. Verfasst von Xing Luo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Biology, National Cancer Institute, Bethesda, MD20892, United States. Hauptthemen laut MEDLINE: Host Factor 1 Protein, RNA, Messenger, RNA, Small Untranslated, Escherichia coli Proteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Institute of Child Health and Human Development, Intramural NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Most bacterial small regulatory RNAs (sRNAs) modulate gene expression by forming complementary base pairs with target messenger RNAs (mRNAs), dependent upon the RNA chaperone Hfq. Hfq has three RNA-binding faces (proximal, rim, and distal), facilitating simultaneous binding of sRNAs and target mRNAs. Here, we systematically examined the functional impact of amino acid substitutions in the RNA-binding faces on in vivo pairing, using the RNA interaction by ligation and sequencing (RIL-seq) approach. The distal and proximal Hfq-binding face mutants retained substantial numbers of RNA–RNA interactions (significant chimera counts or S-chimeras). However, the rim face mutant R16A showed a near-complete loss of S-chimeras, although Hfq R16A retained partial RNA-binding activity as well as partial regulatory activity. Intracellular RIL-seq, a method with fewer in vitro processing steps, led to more S-chimeras in R16A, but there were still fewer than for wild-type Hfq and somewhat different sets of prevalent RNA–RNA pairs. Our analysis provides insights into how the RNA-binding faces of Hfq contribute to pairing in vivo, documents the key role for the rim face in stabilizing RNA pairs on Hfq, and highlights intriguing differences captured by different RNA–RNA interactome approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Molecular Biology, National Cancer Institute, Bethesda, MD20892, United States.
- Division of Molecular and Cellular Biology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD 20892, United States.
- Bioinformatics and Scientific Programming Core, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD 20892, United States.
- Biology of Spirochetes Unit, Laboratory of Bacteriology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892, United States.
ORCID-Profile: Xing Luo, Philip P Adams, Ryan K Dale, Gisela Storz, Susan Gottesman
Förderung
- National Institute of Child Health and Human Development
- Intramural NIH HHS
- National Institutes of Health
- National Cancer Institute
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Luo, X., Zhang, A., Esnault, C., De Mets, F., Adams, P. P., Dale, R. K., Storz, G., & Gottesman, S. (2025). RNA–RNA interactome approaches provide in vivo evidence for a critical role of the Hfq rim face in sRNA–mRNA pairing. Nucleic Acids Research, 53(22). https://doi.org/10.1093/nar/gkaf1313
Vancouver
Luo X, Zhang A, Esnault C, De Mets F, Adams PP, Dale RK, et al. RNA–RNA interactome approaches provide in vivo evidence for a critical role of the Hfq rim face in sRNA–mRNA pairing. Nucleic Acids Research. 2025;53(22). doi:10.1093/nar/gkaf1313
BibTeX
@article{Luo2025,
author = {Luo, Xing and Zhang, Aixia and Esnault, Caroline and De Mets, François and Adams, Philip P and Dale, Ryan K and Storz, Gisela and Gottesman, Susan},
title = {RNA–RNA interactome approaches provide in vivo evidence for a critical role of the Hfq rim face in sRNA–mRNA pairing},
journal = {Nucleic Acids Research},
year = {2025},
volume = {53},
number = {22},
doi = {10.1093/nar/gkaf1313}
}
EUVIMED